Fidelity Group of Funds > Fidelity Advisor Series VII
Fidelity Advisor Health Care Fund
$4.90B
Avg Monthly Net Assets
$4.82B
Total Assets
$203.92M
Total Liabilities
$4.61B
Net Assets
Fidelity Advisor Health Care Fund is a Mutual Fund in Fidelity Advisor Series VII
from Fidelity Group of Funds,
based in Massachusetts,
United States of America.
The fund has five share classes
and monthly net assets of $4.90B.
On September 25th, 2024 it reported 104 holdings, the largest
being BOSTON SCIENTIFIC CORP (9.5%), ELI LILLY and CO (8.2%) and UNITEDHEALTH GROUP INC (7.8%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Ticker | Monthly Returns (2 years) |
|---|---|---|---|
| Fidelity Advisor Health Care Fund - Class A | C000014559 | FACDX | |
| Fidelity Advisor Health Care Fund - Class C | C000014561 | FHCCX | |
| Fidelity Advisor Health Care Fund - Class I | C000014563 | FHCIX | |
| Fidelity Advisor Health Care Fund - Class M | C000014562 | FACTX | |
| Fidelity Advisor Health Care Fund - Class Z | C000205006 | FIKCX |
Holdings
From latest NPORT-P, filed September 25th, 2024 for period ending July 31st, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| 10X GENOMICS INC | Long | Equity-common | US | $33M | 2M | 0.72 |
| ACELYRIN INC | Long | Equity-common | US | $4M | 600K | 0.08 |
| ACUMEN PHARMACEUTICALS INC | Long | Equity-common | US | $2M | 700K | 0.05 |
| AGILON HEALTH INC | Long | Equity-common | US | $22M | 3M | 0.47 |
| ALEDADE INC SER B1 PC PP | Long | Equity-preferred | US | $5M | 131K | 0.11 |
| ALEDADE INC SER E1 PC PP | Long | Equity-preferred | US | $2M | 47K | 0.04 |
| ALIGNMENT HEALTHCARE INC | Long | Equity-common | US | $31M | 4M | 0.66 |
| ALLOGENE THERAPEUTICS INC | Long | Equity-common | US | $9M | 3M | 0.19 |
| ALNYLAM PHARMACEUTICALS INC | Long | Equity-common | US | $101M | 425K | 2.19 |
| APOGEE THERAPEUTICS INC | Long | Equity-common | US | $2M | 33K | 0.04 |
| ARCELLX INC | Long | Equity-common | US | $15M | 240K | 0.32 |
| ARCUS BIOSCIENCES INC | Long | Equity-common | US | $7M | 450K | 0.16 |
| ARGENX SE SPONSORED ADR | Long | Equity-common | NL | $95M | 184K | 2.06 |
| ASCENDIS PHARMA AS SPON ADR (ASCENDIS PHARMA A/S) | Long | Equity-common | DK | $69M | 515K | 1.49 |
| ASIMOV INC SER B PC PP | Long | Equity-preferred | US | $3M | 68K | 0.07 |
| ASTRAZENECA PLC | Long | Equity-common | GB | $70M | 440K | 1.51 |
| AVIDITY BIOSCIENCES (AVIDITY BIOSCIENCES INC) | Long | Equity-common | US | $18M | 400K | 0.40 |
| BLUEPRINT MEDICINES CORP | Long | Equity-common | US | $43M | 400K | 0.94 |
| BOSTON SCIENTIFIC CORP | Long | Equity-common | US | $438M | 6M | 9.49 |
| BRIGHTSPRING HEALTH SERVICES INC | Long | Equity-common | US | $23M | 2M | 0.50 |
| BRUKER CORP | Long | Equity-common | US | $47M | 680K | 1.01 |
| CARGO THERAPEUTICS INC | Long | Equity-common | US | $11M | 637K | 0.24 |
| CARIS LIFE SCIENCES INC PP | Long | Equity-common | US | $3M | 1M | 0.07 |
| CARIS LIFE SCIENCES INC SER D PC PP | Long | Equity-preferred | US | $6M | 2M | 0.12 |
| CARTESIAN THERAPEUTICS INC PIPE | Long | Equity-common | US | $4M | 230K | 0.08 |
| CELLDEX THERAPEUTICS INC | Long | Equity-common | US | $13M | 340K | 0.28 |
| CENTENE CORP (CENTENE CORP DEL) | Long | Equity-common | US | $55M | 720K | 1.20 |
| CIGNA GROUP (THE) | Long | Equity-common | US | $158M | 454K | 3.43 |
| CLEERLY INC SER C PC PP | Long | Equity-preferred | US | $10M | 882K | 0.21 |
| CONTINEUM THERAPEUTICS INC CL A | Long | Equity-common | US | $3M | 128K | 0.06 |
| CVS HEALTH CORP | Long | Equity-common | US | $52M | 860K | 1.12 |
| CYTOKINETICS INC | Long | Equity-common | US | $47M | 800K | 1.02 |
| DANAHER CORP | Long | Equity-common | US | $294M | 1M | 6.37 |
| DEXCOM INC | Long | Equity-common | US | $15M | 220K | 0.32 |
| DMED BIOPHARMACEUTICAL CO LTD SER C PC PP | Long | Equity-preferred | CN | $1M | 236K | 0.02 |
| EDWARDS LIFESCIENCES CORP | Long | Equity-common | US | $13M | 210K | 0.29 |
| ELEMENT BIOSCIENCES INC SER C PC PP | Long | Equity-preferred | US | $4M | 377K | 0.09 |
| ELEMENT BIOSCIENCES INC SER D PC PP | Long | Equity-preferred | US | $2M | 247K | 0.04 |
| ELEMENT BIOSCIENCES INC SER D1 PC PP | Long | Equity-preferred | US | $2M | 247K | 0.04 |
| ELEVANCE HEALTH INC | Long | Equity-common | US | $85M | 160K | 1.84 |
| ELEVATEBIO LLC SER C PC PP (ELEVATEBIO, LLC) | Long | Equity-preferred | US | $518K | 163K | 0.01 |
| ELI LILLY and CO | Long | Equity-common | US | $380M | 472K | 8.23 |
| ENDEAVOR BIOMEDICINES INC SERIES C PC PP | Long | Equity-preferred | US | $6M | 864K | 0.13 |
| ENLIVEN THERAPEUTICS INC | Long | Equity-common | US | $7M | 280K | 0.16 |
| EXACT SCIENCES CORP | Long | Equity-common | US | $51M | 1M | 1.11 |
| FAHEAL THRIVE HOLDINGS LLC | Long | Equity-common | US | $3M | 328K | 0.07 |
| Fidelity Cash Central Fund (Fidelity Revere Street Trust) | Long | Short-term investment vehicle | US | $9M | 9M | 0.20 |
| Fidelity Securities Lending Cash Central Fund (Fidelity Revere Street Trust) | Long | Short-term investment vehicle | US | $193M | 193M | 4.19 |
| GALVANIZE THERAPEUTICS CONV 6% 02/28/2027 P/P | Long | Debt | US | $2M | – | 0.05 |
| GALVANIZE THERAPEUTICS SER B PC PERP PP | Long | Equity-preferred | US | $2M | 3M | 0.05 |
| GLAUKOS CORP | Long | Equity-common | US | $62M | 525K | 1.33 |
| IMMUNOCORE HOLDINGS LTD ADR (IMMUNOCORE HOLDINGS PLC) | Long | Equity-common | GB | $10M | 261K | 0.22 |
| INSCRIPTA INC SER E PC PP | Long | Equity-preferred | US | $2M | 826K | 0.05 |
| INSIGHTEC LTD SER G PC PP | Long | Equity-preferred | IL | $7M | 7M | 0.14 |
| INSPIRE MEDICAL SYSTEMS INC | Long | Equity-common | US | $40M | 285K | 0.87 |
| INSULET CORP | Long | Equity-common | US | $101M | 520K | 2.19 |
| INTELLIA THERAPEUTICS INC | Long | Equity-common | US | $9M | 360K | 0.20 |
| INTUITIVE SURGICAL INC | Long | Equity-common | US | $69M | 156K | 1.50 |
| IQVIA HOLDINGS INC | Long | Equity-common | US | $56M | 228K | 1.22 |
| JANUX THERAPEUTICS INC | Long | Equity-common | US | $17M | 428K | 0.38 |
| KARDIUM INC CONV 10% 12/31/2026 PP (KARDIUM INC/CA) | Long | Equity-preferred | CA | $8M | – | 0.16 |
| KEROS THERAPEUTICS (KEROS THERAPEUTICS INC) | Long | Equity-common | US | $20M | 400K | 0.43 |
| LEGEND BIOTECH CORP SPON ADR | Long | Equity-common | KY | $88M | 2M | 1.91 |
| LIFESTANCE HEALTH GROUP INC | Long | Equity-common | US | $24M | 4M | 0.53 |
| MASIMO CORP | Long | Equity-common | US | $59M | 550K | 1.28 |
| MCKESSON CORP | Long | Equity-common | US | $77M | 124K | 1.66 |
| MEDICAL MICROINSTRUMENTS INC SER C PC PP | Long | Equity-preferred | US | $7M | 200K | 0.14 |
| MEDICAL MICROINSTRUMENTS INC WT 02/16/2031 PP | Long | Equity-common | US | $122K | 10K | 0.00 |
| MERCK and CO INC NEW | Long | Equity-common | US | $181M | 2M | 3.92 |
| MERUS B.V. (MERUS NV) | Long | Equity-common | NL | $33M | 613K | 0.71 |
| MOONLAKE IMMUNOTHERAPEUTICS | Long | Equity-common | KY | $13M | 320K | 0.29 |
| NUVALENT INC-A | Long | Equity-common | US | $34M | 425K | 0.74 |
| OMADA HEALTH INC SER E PC PP | Long | Equity-preferred | US | $6M | 1M | 0.12 |
| ORUKA THERAPEUTICS INC PIPE | Long | Equity-common | US | $5M | 917K | 0.12 |
| PENUMBRA INC | Long | Equity-common | US | $140M | 840K | 3.04 |
| PERSPECTIVE THERAPEUTICS INC | Long | Equity-common | US | $95K | 7K | 0.00 |
| PHARVARIS BV | Long | Equity-common | NL | $8M | 478K | 0.18 |
| PHREESIA INC | Long | Equity-common | US | $23M | 904K | 0.49 |
| POSEIDA THERAPEUTICS INC | Long | Equity-common | US | $5M | 1M | 0.11 |
| PRIVIA HEALTH GROUP INC | Long | Equity-common | US | $52M | 3M | 1.12 |
| PROCEPT BIOROBOTICS CORP | Long | Equity-common | US | $24M | 380K | 0.52 |
| RAPPORT THERAPEUTICS INC | Long | Equity-common | US | $4M | 160K | 0.08 |
| REGENERON PHARMACEUTICALS INC | Long | Equity-common | US | $201M | 187K | 4.36 |
| REPLIGEN (REPLIGEN CORP) | Long | Equity-common | US | $12M | 72K | 0.26 |
| ROYALTY PHARMA PLC | Long | Equity-common | GB | $39M | 1M | 0.85 |
| SALUDA MEDICAL INC SER E PC PP | Long | Equity-preferred | US | $5M | 782K | 0.12 |
| SAREPTA THERAPEUTICS INC | Long | Equity-common | US | $23M | 160K | 0.49 |
| SPYRE THERAPEUTICS INC | Long | Equity-common | US | $9M | 330K | 0.20 |
| STRUCTURE THERAPEUTICS INC ADR | Long | Equity-common | KY | $15M | 412K | 0.33 |
| STRYKER CORP | Long | Equity-common | US | $108M | 330K | 2.34 |
| SUMMIT THERAPEUTICS INC | Long | Equity-common | US | $8M | 750K | 0.18 |
| SURGERY PARTNERS INC | Long | Equity-common | US | $68M | 2M | 1.48 |
| THERMO FISHER SCIENTIFIC INC | Long | Equity-common | US | $63M | 102K | 1.36 |
| UCB SA | Long | Equity-common | BE | $61M | 365K | 1.32 |
| UNITEDHEALTH GROUP INC | Long | Equity-common | US | $360M | 625K | 7.80 |
| VAXCYTE INC | Long | Equity-common | US | $69M | 875K | 1.50 |
| VEEVA SYS INC CL A | Long | Equity-common | US | $58M | 300K | 1.25 |
| VIKING THERAPEUTICS INC | Long | Equity-common | US | $2M | 37K | 0.05 |
| VIRIDIAN THERAPEUTICS INC | Long | Equity-common | US | $17M | 1M | 0.37 |
| WEST PHARMACEUTICAL SVCS INC | Long | Equity-common | US | $6M | 18K | 0.12 |
| WUGEN INC CONV 10% 06/14/2025 PP | Long | Debt | US | $1M | – | 0.03 |
| WUGEN INC SER B PC PP | Long | Equity-preferred | US | $1M | 300K | 0.03 |
| XENON PHARMACEUTICALS INC | Long | Equity-common | CA | $33M | 760K | 0.71 |
| ZEALAND PHARMA A/S | Long | Equity-common | DK | $1M | 9K | 0.03 |
Address
Fidelity Advisor Series VII
245 Summer Street
Boston
Massachusetts
02210
United States of America
Directors
Oscar Munoz
Karen Peetz
Robert A Lawrence
Thomas A Kennedy
Bettina Doulton
Vicki L Fuller
Vijay Advani
Thomas P Bostick
Patricia L Kampling
Donald F Donahue
Michael E Wiley
Susan Tomasky
David M Thomas
Transfer Agents
Fidelity Investments Institutional Operations Company LLC
Pricing Services
INTERCONTINENTAL EXCHANGE INC
REFINITIV US HOLDINGS INC
Custodians
STANDARD CHARTERED BANK
BNP PARIBAS GREECE
SSB GMBH GERMANY - CBF
EUROCLEAR
BANCO NACIONAL DE MEXICO SA
SEB NORWAY
STATE STREET SERVICES (UK) LIMITED
HSBC - JAPAN
BNP PARIBAS NETHERLANDS
CITIBANK SINGAPORE
BNP PARIBAS FRANCE
THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED
Citibank Europe Plc
STATE STREET TRUST COMPANY CANADA
BNP PARIBAS BELGIUM
STATE STREET BANK AND TRUST COMPANY
INTESA SANPAOLO SPA
HSBC AUSTRALIA
CITIBANK N.A.
Shareholder Servicing Agents
Fidelity Investments Institutional Operations Company LLC
Admins
Fidelity Service Company
Brokers
WELLS FARGO and CO
GOLDMAN SACHS GROUP INC (THE)
BARCLAYS PLC
MORGAN STANLEY
ROYAL BANK OF CANADA
BANK OF AMERICA CORPORATION
UBS GROUP AG
CITIGROUP INC
JPMORGAN CHASE and CO
JEFFERIES FINANCIAL GROUP INC